Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer

Read full text Summarise with VIRAT
Authors: Danielle Roman, PharmD, BCOP, PA-C Kaitlyn Reeder
Cited by: 0
References: 5

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The management of metastatic hormone receptor–positive (HR+) and human epidermal growth factor receptor 2–positive (HER2+) breast cancer continues to evolve with the development of novel targeted therapies. At JADPRO Live, presenters discussed therapies for this subtype of breast cancer, adverse events, management strategies, as well as biomarkers to consider when making treatment decisions.

Fields of Study & Subjects

Advanced Breast Cancer Therapies Breast Cancer Treatment Studies HER2/EGFR in Cancer Research

Publication details

Journal / source
Journal of the Advanced Practitioner in Oncology
Volume
17
Issue
2
Publication date
27 February 2026
Language
EN